Avian influenza is an infection caused by avian (bird) influenza (flu) viruses. These influenza viruses occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, but usually do not get sick from them. However, avian influenza is very contagious among birds and can make some domesticated birds, including chickens, ducks, and turkeys, very sick and kill them.
Scientists have identified the virus likely to have caused a pneumonia-like illness that has caused an outbreak in Wuhan, China.
A new study published in the journal Proceedings of the National Academy of Sciences on December 23, 2019, describes a novel device developed by a team of researchers at Penn State and New York University. Not only can this instrument capture different types of virus, it can tell what kind they are.
Normally, bird flu viruses do not spread easily from person to person. But if this does happen, it could trigger a pandemic. Researchers from the MDC and RKI have now explained in the journal Nature Communications what makes the leap from animals to humans less likely.
Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.
A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.
Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.
A new project in Northern Australia will focus on how Australia can better protect and rapidly respond to the growing global risk of emergent infectious diseases which can spread to humans through animals and insects.
The host range of the influenza A virus is restricted by dysregulated expression of the M viral gene segment, according to a study published August 15 in the open-access journal PLOS Pathogens by Anice Lowen and John Steel of Emory University School of Medicine, and colleagues.
An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.
The influenza A viruses, which have instigated deadly pandemics in the past, still remain a major global public health problem until today. Molecules known as virulence factors are produced by bacteria, viruses, and fungi to help them to infect host cells.
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown.
Dubbed ‘Disease X’, scientists believe a future epidemic of the influenza virus could cause millions of deaths worldwide.
New research has taken a step towards understanding how highly pathogenic influenza viruses such as deadly bird flu infect humans.
A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a "pre-pandemic" influenza vaccine is underway at Baylor College of Medicine in Houston.
Veterinary authorities in Bulgaria have called for culling of nearly 8,000 ducks according to a food safety agency yesterday after two more regions there have reported avian flu infection. According to the agency a total of four outbreaks of bird flu have been registered in Bulgaria at this time.
The official signboard-hanging ceremony of the Self-powered Mobile Tracker Research Center took place at UNIST on September 12, 2017.
University of Florida researchers will use a $2.7 million National Institutes of Health grant to study whether they can harness an unusual type of immune cell in pigs to treat and prevent influenza viruses in animals and humans.
InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.
Researchers at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil have discovered a new virus in a migratory bird species.
A systematic mutation analysis has shown that changes in just three amino acids of the avian influenza H7N9 virus receptor binding protein confers specificity for human cells.